Evgeny Zaytsev
Fondateur chez Bering Capital LLC
Profil
Evgeny Zaytsev was the founder of Helix Ventures LLC, founded in 2008, where he held the title of General Partner from 2010 to 2011.
He is also the founder of Bering Capital LLC, founded in 2020, where he currently holds the title of Managing Partner.
In his current roles, Dr. Zaytsev is the Director at NovaDigm Therapeutics, Inc. and the Managing Partner at RMI Partners OOO.
Dr. Zaytsev's former positions include Chairman at InteKrin Therapeutics, Inc. from 2011 to 2018, Director at Adastra Pharmaceuticals, Inc., Director at Aldea Pharmaceuticals, Inc., Independent Director at Clearside Biomedical, Inc. from 2014 to 2018, and Director at Epic Sciences, Inc. He also served as the President of the Global Technology Symposium at Stanford University from 2003 to 2004 and as a Partner at Asset Management Co., specifically Pitch Johnson, from 2001 to 2010.
Additionally, he was the Chief Scientific Officer at Medico-Ecological Institute from 1993 to 2000.
Dr. Zaytsev's education includes a doctorate from Altai State University in 1991 and two additional doctorates from Altai State University in 1993.
He also holds an MBA from Stanford Graduate School of Business, which he obtained in 2002.
Postes actifs de Evgeny Zaytsev
| Sociétés | Poste | Début |
|---|---|---|
NovaDigm Therapeutics, Inc.
 NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Directeur/Membre du Conseil | - |
RMI Partners OOO
 RMI Partners OOO Investment ManagersFinance RusnanoMedInvest (RMI) is a subsidiary of RUSNANO, a 100 percent Russian state-owned company whose mission is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit. RMI was founded in 2012 headquartered in Russian. The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia. | Corporate Officer/Principal | - |
Bering Capital LLC
 Bering Capital LLC Investment ManagersFinance Bering Capital LLC (Bering Capital) is a venture capital firm founded in 2020 by Evgeny Zaytsev. The firm is headquartered in San Francisco, California. | Fondateur | 01/04/2020 |
Anciens postes connus de Evgeny Zaytsev
| Sociétés | Poste | Fin |
|---|---|---|
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Président | 01/12/2018 |
| CLEARSIDE BIOMEDICAL, INC. | Directeur/Membre du Conseil | 26/09/2018 |
Asset Management Co.
 Asset Management Co. Investment ManagersFinance Asset Management Co. is a venture capital firm. The company was founded in 1965 and is headquartered in East Palo Alto, CA. | Corporate Officer/Principal | 30/04/2010 |
| Stanford University | Corporate Officer/Principal | 01/03/2004 |
| Medico-Ecological Institute | Directeur Technique/Scientifique/R&D | 01/08/2000 |
Formation de Evgeny Zaytsev
| Stanford Graduate School of Business | Masters Business Admin |
| Altai State University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLEARSIDE BIOMEDICAL, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
Asset Management Co.
Asset Management Co. Investment ManagersFinance Asset Management Co. is a venture capital firm. The company was founded in 1965 and is headquartered in East Palo Alto, CA. | Finance |
Helix Ventures LLC
 Helix Ventures LLC Investment ManagersFinance Helix Ventures LLC (Helix Ventures) is a venture capital firm founded in 2008 by Graham Crooke, Philip Sawyer and Evgeny Zaytsev. The firm is headquartered in Palo Alto, California. | Finance |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | Health Technology |
Aldea Pharmaceuticals, Inc.
 Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aldea Pharmaceuticals, Inc. develops novel enzyme activators to enhance the removal of toxic aldehydes. It targets Aldehyde metabolism dysfunction which is associated with a variety of diseases from acute alcohol toxicity to orphan indications such as Fanconi anemia. The company was founded by Daria Mochly-Rosen, Che-Hong Chen and Wenjin Yang in 2011 and is headquartered in Redwood City, CA. | Health Technology |
Epic Sciences, Inc.
 Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Health Technology |
NovaDigm Therapeutics, Inc.
NovaDigm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology NovaDigm Therapeutics, Inc. developes innovative immunotherapeutics and preventative vaccines. It protect patients from fungal and bacterial infections, which can be recurrent, drug-resistant and in some cases, life-threatening. The firm NDV-3A, is the first vaccine to demonstrate preclinical efficacy in reducing the severity of disease caused by both fungal and bacterial pathogens. NDV-3A is in Phase 2 clinical development for recurrent vulvovaginal candidiasis (RVVC) with follow-on indications planned for Candida, a fungal pathogen, and Staphylococcus aureus, including MRSA. The company was founded by Toumas R. Holmberg, Michael R. Yeaman, Frederick M.Haneyand John E. Eswards Jr. in 2005 and is headquartered in Grand Forks ND. | Health Technology |
Adastra Pharmaceuticals, Inc.
 Adastra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Adastra Pharmaceuticals, Inc. engages in the provision of clinical and commercial development of proprietary drugs for the treatment of various cancers. The company was founded by Tracy L. Parrott in 2005 and is headquartered in Princeton, NJ. | Health Technology |
RMI Partners OOO
RMI Partners OOO Investment ManagersFinance RusnanoMedInvest (RMI) is a subsidiary of RUSNANO, a 100 percent Russian state-owned company whose mission is to develop the Russian nanotechnology industry through co investment in nanotechnology projects with substantial economic potential or social benefit. RMI was founded in 2012 headquartered in Russian. The firm to realize advanced projects in medicine and pharmaceuticals involving the transfer of intellectual property rights and modern pharmaceutical production technology to Russia. | Finance |
Bering Capital LLC
Bering Capital LLC Investment ManagersFinance Bering Capital LLC (Bering Capital) is a venture capital firm founded in 2020 by Evgeny Zaytsev. The firm is headquartered in San Francisco, California. | Finance |